BioNTech SE BNTX
NASDAQ BNTX
$96.90 +0.05 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Change in Accured Expenses (2018 - 2020)

Updated

BioNTech SE's Change in Accured Expenses came in at -$19.61 million for Q1 2020, compared with -$22.92 million a year earlier.

Analysis

BioNTech SE (BNTX) Change in Accured Expenses (2018 - 2020) Analysis & Trends

Over the trailing twelve months to Mar 31, 2020, BioNTech SE reported Change in Accured Expenses of -$79.88 million; for FY2019, it was -$90.24 million.

  • Going back by year, Change in Accured Expenses was -$24.9 million in FY2018 and -$5.17 million in FY2017.
  • The Q1 2020 figure represents the highest quarterly Change in Accured Expenses since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BioNTech SE 24.50 Bn -34.86 Bn 10.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -19.61 Mn
Dec 31, 2019 -22.77 Mn
Mar 31, 2019 -22.92 Mn
Dec 31, 2018 -14.57 Mn
API Access

BioNTech SE Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BNTX&period=max&api_key=YOUR_API_KEY